Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 2, 2015American Journal of TransplantationOpen Access

Positive Crossmatch Kidney Transplant Recipients Treated With Eculizumab: Outcomes Beyond 1 Year

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLynn D. CornellCSCarrie A. SchinstockMGManish J. Gandhi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cornell et al. (2015) studied this question.

synapsesocial.com/papers/69f7f1a9976531054ef75b4ehttps://doi.org/10.1111/ajt.13168
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Proteasome inhibition for antibody-mediated rejection2009 · 93 citations
  2. 2Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.1995 · 214 citations
  3. 3Calculated PRA: Initial Results Show Benefits for Sensitized Patients and a Reduction in Positive Crossmatches2010 · 167 citations
  4. 4Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients2011 · 575 citations
  5. 5Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up Biopsies2013 · 178 citations